Vidac Pharma Holding Plc (ETR:T9G)
Germany · Delayed Price · Currency is EUR 0.4810
+0.0010 (0.21%)
At close: Jul 7, 2026
Vidac Pharma Holding Market Cap
Vidac Pharma Holding has a market cap or net worth of €25.04 million as of July 7, 2026.
Market Cap
25.04M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.48
Market Cap Chart
Since December 15, 2025, Vidac Pharma Holding's market cap has decreased from 26.85M to 25.04M, a decrease of -6.73%. That is a compound annual growth rate of -11.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 25.04M | -9.51% |
| Dec 30, 2025 | 27.67M | 3.08% |
| Dec 15, 2025 | 26.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 80.40M |
| 2invest AG | 45.29M |
| Biomark Diagnostics | 32.80M |
| Paion AG | 392.35K |
| co.don AG | 374.13K |
| bioXXmed AG | 213.41K |
| MagForce AG | 91.72K |